Moreover, rapamycin and rapalogs, inhibitors of the nutrient sensor mTOR and the only pharmacological agents that are generally agreed to modulate lifespan extension, are important therapeutic tools for the treatment of several types of cancer, such as mantle cell lymphoma, endometrial cancer, and renal cell carcinoma [79]. The gene discussed is MTOR; the disease is cancer.